Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Usability of PointCheck, a Novel Optical Technology for Screening Non-Invasively Severe Neutropenia

NCT04448314 is registered in ClinicalTrials.gov with Leuko Labs, Inc. as lead sponsor.

NCT NCT04448314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04448314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Usability of PointCheck, a Novel Optical Technology for Screening Non-Invasively Severe Neutropenia
Lead sponsor
Leuko Labs, Inc.
Phase
Observational
Overall status
Completed
Start date
February 11, 2020
Completion date
June 30, 2023
Enrollment
94 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced neutropenia, neoplasms